Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? No.

× No keyword cloud information.

5 in total

1. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

Authors: Shelley R Salpeter; Nicholas S Buckley; Edwin E Salpeter
Journal: J Gen Intern Med Date: 2006-10 Impact factor: 5.128

2. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.

Authors: S I Rennard; W Anderson; R ZuWallack; J Broughton; W Bailey; M Friedman; M Wisniewski; K Rickard
Journal: Am J Respir Crit Care Med Date: 2001-04 Impact factor: 21.405

Review 3. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.

Authors: S Appleton; P Poole; B Smith; A Veale; T J Lasserson; M M Chan
Journal: Cochrane Database Syst Rev Date: 2006-07-19

4. Addition of salmeterol to existing treatment in patients with COPD: a 12 month study.

Authors: R A Stockley; N Chopra; L Rice
Journal: Thorax Date: 2006-02 Impact factor: 9.139

5. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors: Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal: N Engl J Med Date: 2007-02-22 Impact factor: 91.245

5 in total